
Dicaltrol0.25 mcg
Drug International Ltd.
Calcitriol is the active hormonal form of vitamin D3 (1,25-dihydroxycholecalciferol).
Calcitriol is the active hormonal form of vitamin D3 (1,25-dihydroxycholecalciferol). It is FDA-approved and guideline-supported for the following indications:
| Indication | Adult Dose | Pediatric Dose |
|---|---|---|
| Secondary hyperparathyroidism / hypocalcemia in dialysis patients | Initial: 0.25 mcg orally once daily; may increase by 0.25 mcg/day at 4-8 week intervals based on serum calcium and PTH levels (typical range 0.25-1 mcg/day). | Not well established in dialysis patients under 3 years; specialist-guided weight-based dosing used in older children. |
| Predialysis chronic kidney disease | 0.25 mcg orally once daily; may increase to 0.5 mcg/day if needed under monitoring. | Safety and efficacy not well established; use only under specialist supervision. |
| Hypoparathyroidism (surgical/idiopathic) | Initial: 0.25 mcg orally once daily in the morning; titrate by 0.25 mcg/day every 2-4 weeks based on serum calcium (usual maintenance 0.5-2 mcg/day). | Children 1-5 years: 0.25-0.75 mcg/day; children over 6 years: dosed as adults, under specialist supervision. |
Doses must always be individualized based on serum calcium, phosphate, and PTH levels, with regular monitoring, particularly during dose titration.
The most significant adverse effect of Calcitriol is hypercalcemia (vitamin D toxicity), which requires prompt medical attention. Symptoms and effects may include:
Report any symptoms suggestive of hypercalcemia to a physician promptly, as this is the central safety concern requiring regular calcium monitoring during treatment.
Calcitriol is contraindicated in patients with:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.